Risk factors for chronic renal dysfunction in cardiac allograft recipients

被引:33
|
作者
Esposito, C
Semeraro, L
Bellotti, N
Fasoli, G
Fornoni, A
Rampino, T
Klersy, C
Campana, C
Gavazzi, A
Viganò, M
Dal Canton, A
机构
[1] Univ Pavia, IRCCS, Policlin San Matteo, Dept Internal Med & Nephrol, I-27100 Pavia, Italy
[2] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiol, I-27100 Pavia, Italy
[3] Univ Pavia, IRCCS, Policlin San Matteo, Div Cardiac Surg, I-27100 Pavia, Italy
[4] Univ Pavia, IRCCS, Policlin San Matteo, Sci Adm, I-27100 Pavia, Italy
来源
NEPHRON | 2000年 / 84卷 / 01期
关键词
cardiac allograft recipients; renal function; heart transplantation; ciclosporin;
D O I
10.1159/000045534
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Renal dysfunction is one of the most common and threatening complications in heart transplant recipients. Even if ciclosporin seems to play a central role in inducing renal damage, other factors may concur or predispose to renal injury. In order to identify factors responsible for renal dysfunction, we retrospectively studied a cohort of 114 cardiac transplant recipients during a follow-up period of at least 3 years. The patients had a normal renal function before and 0.5 months after heart transplantation. Doubling of baseline serum creatinine or attainment of serum creatinine steadily above 176.8 mu mol/l (2.0 mg/dl) was used as criterion to define the end-point renal dysfunction. A series of clinical and laboratory variables were obtained from the patients' charts at different time intervals, and their prognostic value for the occurrence of renal dysfunction was calculated by Cox proportional hazards models. 23 out of 114 patients reached the end point after a median time period of 21 months. High serum triglyceride, alanine aminotransferase, alkaline phosphatase, ciclosporin, urea, glucose, and hemoglobin levels were shown to be associated with the development of renal dysfunction. Four variables, i.e., triglyceride, ciclosporin, urea, and alkaline phosphatase, had an independent prognostic value. Our results confirm a role for ciclosporin in inducing renal dysfunction and identify hyperlipidemia and an increased plasma urea level as risk factors for renal dysfunction in heart transplant recipients. Copyright (C) 2000 S. Karger AG, Basel.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 50 条
  • [1] Risk factors for chronic renal dysfunction in lung transplant recipients
    Esposito, Ciro
    De Mauri, Andreana
    Vitulo, Patrizio
    Oggionni, Tiberio
    Cornacchia, Flavia
    Valentino, Rossella
    Grosjean, Fabrizio
    Torreggiani, Massimo
    Dal Canton, Antonio
    TRANSPLANTATION, 2007, 84 (12) : 1701 - 1703
  • [2] Risk Factors for Chronic Renal Insufficiency Following Cardiac Transplantation
    Lachance, Kim
    White, Michel
    de Denus, Simon
    ANNALS OF TRANSPLANTATION, 2015, 20
  • [3] Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease
    Ahmad, Mufazzal
    Robert, Richardson
    Bargman, Joanne M.
    Oreopoulos, Dimitrios
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2008, 40 (04) : 1083 - 1087
  • [4] Advantages of peritoneal dialysis in comparison to hemodialysis, in cardiac allograft recipients with end stage renal disease
    Mufazzal Ahmad
    Richardson Robert
    Joanne M. Bargman
    Dimitrios Oreopoulos
    International Urology and Nephrology, 2008, 40 : 1083 - 1087
  • [5] CLINICAL OUTCOME OF INTERVAL CADAVERIC RENAL-TRANSPLANTATION IN CARDIAC ALLOGRAFT RECIPIENTS
    KUO, PC
    LUIKART, H
    BUSSEHENRY, S
    HUNT, SA
    VALANTINE, HA
    STINSON, EB
    OYER, PE
    SCANDLING, JD
    ALFREY, EJ
    DAFOE, DC
    CLINICAL TRANSPLANTATION, 1995, 9 (02) : 92 - 97
  • [6] Is halving ciclosporin dose and introducing mycophenolate beneficial in chronic renal allograft dysfunction?
    Seron, Daniel
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2007, 3 (04): : 198 - 199
  • [7] The Impact of Donor and Recipient Renal Dysfunction on Cardiac Allograft Survival: Insights Into Reno-Cardiac Interactions
    Laur, Olga
    Brisco, Meredith A.
    Kula, Alexander J.
    Cheng, Susan J.
    Mangi, Abeel A.
    Bellumkonda, Lavanya
    Jacoby, Daniel L.
    Coca, Steven
    Tang, W. H. Wilson
    Parikh, Chirag R.
    Testani, Jefirey M.
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (05) : 368 - 375
  • [8] RAISED PLASMA-LEVELS OF ATRIAL-NATRIURETIC-FACTOR IN CARDIAC ALLOGRAFT RECIPIENTS - EVIDENCE OF INCREASED CARDIAC SECRETION AND DECREASED RENAL CLEARANCE
    LANG, CC
    MORELAND, T
    CHOY, AMJ
    PRINGLE, TH
    MCNEILL, GP
    STRUTHERS, AD
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 48 (06) : 429 - 434
  • [9] Incidence of Neoplastic Disease in Cardiac Allograft Recipients
    Savasta, Marcello
    Lentini, Salvatore
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2011, 12 (04) : 219 - 226
  • [10] Long-term evolution, secular trends, and risk factors of renal dysfunction following cardiac transplantation
    Lachance, Kim
    White, Michel
    Carrier, Michel
    Mansour, Asmaa
    Racine, Normand
    Liszkowski, Mark
    Ducharme, Anique
    de Denus, Simon
    TRANSPLANT INTERNATIONAL, 2014, 27 (08) : 824 - 837